Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Huber

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Molecular Cell|December 17, 2016
Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication ForksSotirios K Sotiriou, Irene Kamileri, Natalia Lugli, et al.
Nature Methods|July 11, 2018
Genome-wide C-SWAT library for high-throughput yeast genome taggingMatthias Meurer, Yuanqiang Duan, Ehud Sass, et al.
Nature Cancer|May 1, 2023
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancerAnne I Kraemer, Chloe Chong, Florian Huber, et al.
Nature Communications|March 16, 2024
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptidesHumberto J Ferreira, Brian J Stevenson, HuiSong Pak, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Nature Biotechnology|November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.
Nature Communications|March 12, 2020
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomesChloe Chong, Markus Müller, HuiSong Pak, et al.
NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Molecular Cell|December 17, 2016
Mammalian RAD52 Functions in Break-Induced Replication Repair of Collapsed DNA Replication ForksSotirios K Sotiriou, Irene Kamileri, Natalia Lugli, et al.
Nature Methods|July 11, 2018
Genome-wide C-SWAT library for high-throughput yeast genome taggingMatthias Meurer, Yuanqiang Duan, Ehud Sass, et al.
Nature Cancer|May 1, 2023
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancerAnne I Kraemer, Chloe Chong, Florian Huber, et al.
Nature Communications|March 16, 2024
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptidesHumberto J Ferreira, Brian J Stevenson, HuiSong Pak, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Nature Biotechnology|November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.
Nature Communications|March 12, 2020
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomesChloe Chong, Markus Müller, HuiSong Pak, et al.
NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.
Pageof 14